| UniProt ID | STABP_HUMAN | |
|---|---|---|
| UniProt AC | O95630 | |
| Protein Name | STAM-binding protein | |
| Gene Name | STAMBP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 424 | |
| Subcellular Localization |
Nucleus. Membrane Peripheral membrane protein. Cytoplasm. Early endosome. |
|
| Protein Description | Zinc metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Does not cleave 'Lys-48'-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways.. | |
| Protein Sequence | MSDHGDVSLPPEDRVRALSQLGSAVEVNEDIPPRRYFRSGVEIIRMASIYSEEGNIEHAFILYNKYITLFIEKLPKHRDYKSAVIPEKKDTVKKLKEIAFPKAEELKAELLKRYTKEYTEYNEEKKKEAEELARNMAIQQELEKEKQRVAQQKQQQLEQEQFHAFEEMIRNQELEKERLKIVQEFGKVDPGLGGPLVPDLEKPSLDVFPTLTVSSIQPSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSDHGDVSL ------CCCCCCCCC | 38.01 | 30108239 | |
| 19 | Phosphorylation | EDRVRALSQLGSAVE HHHHHHHHHHCCCEE | 23.52 | 30850117 | |
| 39 | Phosphorylation | PPRRYFRSGVEIIRM CCHHHCCCCCEEEEE | 36.97 | 46163135 | |
| 48 | Phosphorylation | VEIIRMASIYSEEGN CEEEEEEECCCCCCC | 16.83 | 28348404 | |
| 50 | Phosphorylation | IIRMASIYSEEGNIE EEEEEECCCCCCCEE | 13.92 | 28122231 | |
| 51 | Phosphorylation | IRMASIYSEEGNIEH EEEEECCCCCCCEEE | 27.74 | 28348404 | |
| 81 | Ubiquitination | LPKHRDYKSAVIPEK CCCCCCHHHCCCCCC | 35.91 | - | |
| 82 | Phosphorylation | PKHRDYKSAVIPEKK CCCCCHHHCCCCCCH | 22.87 | 27470641 | |
| 88 | Acetylation | KSAVIPEKKDTVKKL HHCCCCCCHHHHHHH | 51.07 | 23749302 | |
| 88 | Ubiquitination | KSAVIPEKKDTVKKL HHCCCCCCHHHHHHH | 51.07 | - | |
| 96 | Ubiquitination | KDTVKKLKEIAFPKA HHHHHHHHHHCCCCH | 56.82 | - | |
| 102 | Sumoylation | LKEIAFPKAEELKAE HHHHCCCCHHHHHHH | 63.07 | - | |
| 102 | Sumoylation | LKEIAFPKAEELKAE HHHHCCCCHHHHHHH | 63.07 | - | |
| 102 | Ubiquitination | LKEIAFPKAEELKAE HHHHCCCCHHHHHHH | 63.07 | - | |
| 107 | Ubiquitination | FPKAEELKAELLKRY CCCHHHHHHHHHHHH | 42.99 | 21890473 | |
| 107 | Ubiquitination | FPKAEELKAELLKRY CCCHHHHHHHHHHHH | 42.99 | 21890473 | |
| 112 | Ubiquitination | ELKAELLKRYTKEYT HHHHHHHHHHHHHHH | 56.85 | - | |
| 114 | Phosphorylation | KAELLKRYTKEYTEY HHHHHHHHHHHHHHH | 22.15 | 23403867 | |
| 116 | Ubiquitination | ELLKRYTKEYTEYNE HHHHHHHHHHHHHHH | 39.53 | - | |
| 118 | Phosphorylation | LKRYTKEYTEYNEEK HHHHHHHHHHHHHHH | 13.36 | 27642862 | |
| 121 | Phosphorylation | YTKEYTEYNEEKKKE HHHHHHHHHHHHHHH | 21.77 | 27642862 | |
| 136 | Sulfoxidation | AEELARNMAIQQELE HHHHHHHHHHHHHHH | 2.64 | 21406390 | |
| 144 | Ubiquitination | AIQQELEKEKQRVAQ HHHHHHHHHHHHHHH | 80.82 | - | |
| 153 | Ubiquitination | KQRVAQQKQQQLEQE HHHHHHHHHHHHHHH | 37.68 | 21890473 | |
| 153 | Ubiquitination | KQRVAQQKQQQLEQE HHHHHHHHHHHHHHH | 37.68 | 21890473 | |
| 153 | Acetylation | KQRVAQQKQQQLEQE HHHHHHHHHHHHHHH | 37.68 | 12650301 | |
| 168 | Sulfoxidation | QFHAFEEMIRNQELE HHHHHHHHHHCHHHH | 2.48 | 30846556 | |
| 176 | Ubiquitination | IRNQELEKERLKIVQ HHCHHHHHHHHHHHH | 61.84 | - | |
| 180 | Ubiquitination | ELEKERLKIVQEFGK HHHHHHHHHHHHHCC | 47.23 | - | |
| 187 | Ubiquitination | KIVQEFGKVDPGLGG HHHHHHCCCCCCCCC | 49.11 | - | |
| 214 | Phosphorylation | VFPTLTVSSIQPSDC CCCEEEECCCCHHHC | 19.25 | 30631047 | |
| 236 | Phosphorylation | KPPVVDRSLKPGALS CCCCCCCCCCCCCCC | 35.96 | 29978859 | |
| 238 | Ubiquitination | PVVDRSLKPGALSNS CCCCCCCCCCCCCCC | 42.52 | - | |
| 243 | Phosphorylation | SLKPGALSNSESIPT CCCCCCCCCCCCCCC | 37.46 | 21082442 | |
| 245 | Phosphorylation | KPGALSNSESIPTID CCCCCCCCCCCCCCC | 29.37 | 21082442 | |
| 247 | Phosphorylation | GALSNSESIPTIDGL CCCCCCCCCCCCCCC | 33.42 | 15314065 | |
| 250 | Phosphorylation | SNSESIPTIDGLRHV CCCCCCCCCCCCCEE | 29.99 | 28450419 | |
| 255 | Methylation | IPTIDGLRHVVVPGR CCCCCCCCEEEECCC | 26.53 | - | |
| 295 | Phosphorylation | KLMRNEFTITHVLIP HHHCCCCEEEEEEEC | 20.84 | 24114839 | |
| 297 | Phosphorylation | MRNEFTITHVLIPKQ HCCCCEEEEEEECCC | 11.68 | 24114839 | |
| 378 | Ubiquitination | FQETGFFKLTDHGLE CCCCCCEEECCCCHH | 48.49 | - | |
| 393 | Ubiquitination | EISSCRQKGFHPHSK HHHHHHHCCCCCCCC | 44.16 | - | |
| 399 | Phosphorylation | QKGFHPHSKDPPLFC HCCCCCCCCCCCCEE | 43.11 | 46163141 | |
| 400 | Ubiquitination | KGFHPHSKDPPLFCS CCCCCCCCCCCCEEC | 71.82 | - | |
| 419 | Phosphorylation | TVVDRAVTITDLR-- EEEECEEEEECCC-- | 19.71 | 26437602 | |
| 424 | Methylation | AVTITDLR------- EEEEECCC------- | 47.51 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STABP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STABP_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614261 | Microcephaly-capillary malformation syndrome (MICCAP) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Promoting bone morphogenetic protein signaling through negativeregulation of inhibitory Smads."; Itoh F., Asao H., Sugamura K., Heldin C.-H., ten Dijke P., Itoh S.; EMBO J. 20:4132-4142(2001). Cited for: FUNCTION, INTERACTION WITH SMAD6 AND SMAD7, SUBCELLULAR LOCATION, ANDPHOSPHORYLATION AT SER-2; SER-48; SER-243; SER-245 AND SER-247. | |